Umoja Biopharma
Provider of immunotherapies intended to transform cancer treatment and improve quality of life. The company's cellular immunotherapy platform uses gene therapy to target cancer cells and delivers to a...
Valuation
$420M
Market implied
Share Price
N/A
Total Raised
$371M
Last Round
N/A